Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation

Details for Australian Patent Application No. 2004278158 (hide)

Owner Pfizer Inc.

Inventors Stupple, Paul Anthony

Agent Shelston IP

Pub. Number AU-B-2004278158

PCT Pub. Number WO2005/033107

Priority 0418566.6 19.08.04 GB; 0325020.6 27.10.03 GB; 0323236.0 03.10.03 GB

Filing date 28 September 2004

Wipo publication date 14 April 2005

Acceptance publication date 13 August 2009

International Classifications

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 31/4745 (2006.01)

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/033107 Priority application(s): WO2005/033107

13 August 2009 Application Accepted

  Published as AU-B-2004278158

10 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004278159-Process for preparing an azabicyclo(3.1.0)hexane compound

2004278134-Wheel for goods wagon and wheel set